Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
| No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
| 1 | ABC transporters |
[1] ABCC8 | D00418 | Minoxidil | [1] 179 |
| 2 | Adrenergic signaling in cardiomyocytes |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 3 | AGE-RAGE signaling pathway in diabetic complications |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 4 | Alcoholism |
[1] DRD2 | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| [1] SLC6A3 | D01296 | Methylphenidate | [7] 6, 13, 34, 84, 113, 179, 206 | ||
| D04999 | |||||
| 5 | Aldosterone synthesis and secretion |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 6 | Amphetamine addiction |
[1] SLC6A3 | D01296 | Methylphenidate | [7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 | |||||
| 7 | Apelin signaling pathway |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 8 | Calcium signaling pathway |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| [1] HTR2A | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 | ||
| 9 | cAMP signaling pathway |
[1] DRD2 | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| 10 | cGMP-PKG signaling pathway |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 11 | Cocaine addiction |
[1] DRD2 | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| [1] SLC6A3 | D01296 | Methylphenidate | [7] 6, 13, 34, 84, 113, 179, 206 | ||
| D04999 | |||||
| 12 | Cortisol synthesis and secretion |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 13 | Cushing syndrome |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 14 | Dopaminergic synapse |
[1] DRD2 | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| [1] SLC6A3 | D01296 | Methylphenidate | [7] 6, 13, 34, 84, 113, 179, 206 | ||
| D04999 | |||||
| 15 | Gap junction |
[2] DRD2, HTR2A | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| 16 | GnRH secretion |
[1] KCNJ11 | D00418 | Minoxidil | [1] 179 |
| 17 | Inflammatory mediator regulation of TRP channels |
[1] HTR2A | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| 18 | Insulin secretion |
[2] ABCC8, KCNJ11 | D00418 | Minoxidil | [1] 179 |
| 19 | Neuroactive ligand-receptor interaction |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| [2] DRD2, HTR2A | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 | ||
| 20 | Parkinson disease |
[1] DRD2 | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| [1] SLC6A3 | D01296 | Methylphenidate | [7] 6, 13, 34, 84, 113, 179, 206 | ||
| D04999 | |||||
| 21 | Pathways in cancer |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 22 | Phospholipase D signaling pathway |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 23 | Rap1 signaling pathway |
[1] DRD2 | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| 24 | Renin secretion |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 25 | Renin-angiotensin system |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 | |||||
| 26 | Serotonergic synapse |
[1] HTR2A | D00426 | Risperidone | [5] 8, 156, 179, 187, 206 |
| [1] SLC6A4 | D00326 | Fluoxetine | [6] 13, 17, 78, 86, 179, 206 | ||
| D00823 | |||||
| 27 | Synaptic vesicle cycle |
[2] SLC6A2, SLC6A3 | D01296 | Methylphenidate | [7] 6, 13, 34, 84, 113, 179, 206 |
| D04999 | |||||
| [1] SLC6A4 | D00326 | Fluoxetine | [6] 13, 17, 78, 86, 179, 206 | ||
| D00823 | |||||
| 28 | Type II diabetes mellitus |
[2] ABCC8, KCNJ11 | D00418 | Minoxidil | [1] 179 |
| 29 | Vascular smooth muscle contraction |
[1] AGTR1 | D00357 | Losartan | [18] 13, 17, 19, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 |
| D08146 |